Physician profile
Reinaldo Morales
NPI 1518285444
$18,867.17
in general payments reported to CMS, 2019-2025
9 companies · $309 in 2025
The $309 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,264 · 2020: $3,045 · 2021: $16.86 · 2022: $4,150 · 2023: $3,019 · 2024: $63.49 · 2025: $309.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,000 · Travel and Lodging: $255 · Food and Beverage: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,000.00 |
| Travel and Lodging | $255.21 |
| Food and Beverage | $136.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $18,682.78 | 2019-2025 | Davinci Xi |
| Boston Scientific Corporation | $41.36 | 2024 | Advantage System |
| Integra Lifesciences Corporation | $34.97 | 2019 | |
| Smith+Nephew, INC. | $23.19 | 2019-2020 | |
| Baxter Healthcare | $19.31 | 2023 | Perclot |
| Merck Sharp & Dohme LLC | $18.53 | 2020 | |
| Urgo Medical North America, LLC | $16.86 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Acell, INC. | $15.90 | 2019 | |
| Covidien LP | $14.27 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reinaldo Morales listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.